Frank A. Anania
Affiliations: | 2018 | Biological and Biomedical Sciences | Emory University, Atlanta, GA |
Area:
Nutrition, Biochemistry, GeneralWebsite:
http://medicine.emory.edu/digestive-diseases/emory-first-faculty-directory/profile.html?f=FANANIAGoogle:
"Frank A. Anania"Bio:
http://www.biomed.emory.edu/academics/faculty-detail.html?action=getFacultyDetail&gdbbsId=afec527e-dd59-41b1-9c3e-2f747ae1cb4c
http://medicine.emory.edu/digestive-diseases/labs/anania-lab/
http://www.emorydailypulse.com/2018/01/22/frank-anania-leaving-emory-university/
https://www.pittmed.health.pitt.edu/aug_2003/PMED.pdf
BETA: Related publications
See more...
Publications
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
Rai RP, Liu Y, Iyer SS, et al. (2020) Blocking integrin αβ-mediated CD4 T cell recruitment to the intestine and liver protects mice from western diet-induced non-alcoholic steatohepatitis. Journal of Hepatology |
Noureddin M, Chan JL, Barradas K, et al. (2020) Attribution of Nonalcoholic Steatohepatitis as an Etiology of Cirrhosis for Clinical Trials Eligibility: Recommendations from the Multi-stakeholder Liver Forum. Gastroenterology |
Gupta B, Liu Y, Chopyk DM, et al. (2020) Western diet-induced increase in colonic bile acids compromises epithelial barrier in nonalcoholic steatohepatitis. Faseb Journal : Official Publication of the Federation of American Societies For Experimental Biology |
Palmer M, Regev A, Lindor K, et al. (2019) Consensus guidelines: best practices for detection, assessment and management of suspected acute drug-induced liver injury occurring during clinical trials in adults with chronic cholestatic liver disease. Alimentary Pharmacology & Therapeutics |
Chinnadurai R, Sands J, Rajan D, et al. (2019) Molecular genetic and immune functional responses distinguish Bone Marrow Mesenchymal Stromal Cells from Hepatic Stellate Cells. Stem Cells (Dayton, Ohio) |
Regev A, Palmer M, Avigan MI, et al. (2019) Review article: consensus guidelines: best practices for detection, assessment and management of suspected acute drug-induced liver injury during clinical trials in patients with nonalcoholic steatohepatitis. Alimentary Pharmacology & Therapeutics |
Kumar P, Raeman R, Chopyk DM, et al. (2018) Adiponectin inhibits hepatic stellate cell activation by targeting the PTEN/AKT pathway. Biochimica Et Biophysica Acta. Molecular Basis of Disease. 1864: 3537-3545 |
Kumar P, Smith T, Raeman R, et al. (2018) Periostin promotes liver fibrogenesis by activating lysyl oxidase in hepatic stellate cells. The Journal of Biological Chemistry |
Pillai AA, Anania FA, Pearlman BL. (2016) Caution: Reactivation of Hepatitis B during Hepatitis C Treatment with Direct-Acting Antiviral Therapy. The American Journal of Gastroenterology. 111: 1854-1856 |
Tedesco D, Thapa M, Gumber S, et al. (2016) CD4+ Foxp3+ T cells promote aberrant IgG production and maintain CD8+ T cell suppression during chronic liver disease. Hepatology (Baltimore, Md.) |